ECM
REGN icon

ExodusPoint Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

ExodusPoint Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Sell
3,756
-66,024
-95% -$50.5M 0.02% 630
2025
Q4 		$53.9M Buy
69,780
+42,048
+152% +$28.6M 0.42% 27
2025
Q3 		$15.6M Buy
+27,732
New +$15.7M 0.16% 117
2025
Q1 		– Sell
-721
Closed -$514K – 1915
2024
Q4 		$514K Sell
721
-7,047
-91% -$5.91M ﹤0.01% 1146
2024
Q3 		$8.17M Buy
7,768
+4,282
+123% +$4.77M 0.05% 275
2024
Q2 		$3.66M Sell
3,486
-9,785
-74% -$9.49M 0.03% 541
2024
Q1 		$12.8M Buy
+13,271
New +$12.6M 0.1% 174
2023
Q3 		– Sell
-2,858
Closed -$2.05M – 2062
2023
Q2 		$2.05M Sell
2,858
-28,975
-91% -$22.3M 0.02% 792
2023
Q1 		$26.2M Buy
31,833
+12,777
+67% +$9.64M 0.22% 73
2022
Q4 		$13.7M Buy
+19,056
New +$14.1M 0.2% 118
2022
Q3 		– Sell
-6,390
Closed -$3.78M – 2233
2022
Q2 		$3.78M Buy
+6,390
New +$4.15M 0.05% 506
2022
Q1 		– Sell
-1,918
Closed -$1.21M – 2596
2021
Q4 		$1.21M Buy
1,918
+786
+69% +$483K 0.01% 968
2021
Q3 		$685K Sell
1,132
-566
-33% -$351K 0.01% 1226
2021
Q2 		$948K Sell
1,698
-15,064
-90% -$7.63M 0.01% 1039
2021
Q1 		$7.93M Buy
16,762
+9,032
+117% +$4.4M 0.12% 169
2020
Q4 		$3.73M Buy
7,730
+4,840
+167% +$2.61M 0.04% 331
2020
Q3 		$1.62M Buy
+2,890
New +$1.75M 0.03% 474
2020
Q2 		– Sell
-2,469
Closed -$1.21M – 1985
2020
Q1 		$1.21M Buy
+2,469
New +$1.02M 0.07% 267
2019
Q1 		– Sell
-4,803
Closed -$1.79M – 752
2018
Q4 		$1.79M Buy
+4,803
New +$1.76M 0.13% 62

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ExodusPoint Capital Management's REGN Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 95% in Q1 2026, selling an estimated $50.5M and leaving 3,756 shares worth $2.9M. The position accounts for 0.02% of the portfolio, ranked #630.

ExodusPoint Capital Management first reported a position in REGN in Q4 2018 and has held it in 19 quarters since. The position peaked at $53.9M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • ExodusPoint Capital Management held 3,756 shares of Regeneron Pharmaceuticals worth $2.9M as of Q1 2026.
  • ExodusPoint Capital Management sold 66,024 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $50.5M.
  • Regeneron Pharmaceuticals made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #630 holding.
  • ExodusPoint Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 19 quarters since.
  • ExodusPoint Capital Management's Regeneron Pharmaceuticals position peaked at $53.9M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.